# Solstice Advanced Materials share price today (Solstice Advanced Materials, Inc., SOLS)

> Solstice Advanced Materials, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. SOLS · Materials · Specialty Chemicals · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/sols

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $61.74 (+37.0% in a year)
- P/E: 47.0× (higher than 58% of the last 1 year)
- Revenue (Jun 2026): $1.1 B (+11.1% on a year ago)
- Profit (Jun 2026): $119 M (+22.7% on a year ago)
- Operating margin: 19.3% (−3.3 points on a year ago)
- ROE: 17%, FY25
- ROIC: 10.6%
- Profit that came in as cash: 142%, last 3 years

The main question: the share price moved +37.0% in a year while yearly earnings per share moved −60.2%. The difference came from the market paying a higher multiple. ## What is the Solstice Advanced Materials share price today? Solstice Advanced Materials, Inc.'s share price was $61.74 at the close on 3 November 2026. That is 12.0% below its average price over the last 200 trading days. In the last 52 weeks it traded between $44 and $86, and at that close it sat 43% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row. Over the last 1 year the share price moved +35% while the S&P 500 moved +11%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Solstice Advanced Materials pay? Solstice Advanced Materials, Inc. has 2 quarters of declared dividends on file, too few for a 12-month total. The most recent declaration was $0.07 for Jun 2026. Solstice Advanced Materials, Inc. declared a dividend in 2 of the last 10 reported quarters, most recently $0.07 for Jun 2026. That is fewer than four quarters, so no 12-month total is shown. ## Which stock lists is Solstice Advanced Materials on? Solstice Advanced Materials is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Solstice Advanced Materials profitable? Solstice Advanced Materials, Inc. earned $119 M of net profit in the Jun 2026 quarter, +22.7% on the same quarter a year earlier. Full-year FY25 profit was $237 M. Over 3 years profit has grown −30.9% a year on average. That is 10.4% of the quarter's revenue. The same quarter a year earlier earned $97.0 M. 1 of the last 10 reported quarters were loss-making. For the full year, FY25 profit was $237 M (−60.1% on the year before). Why profit moved: revenue changed +11.1% on a year earlier and the margin moved −3.3 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −51.5% and revenue +9.2%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Solstice Advanced Materials make, and is it growing? Solstice Advanced Materials, Inc. reported $1.1 B of revenue in the Jun 2026 quarter, +11.1% on the same quarter a year earlier. That is the 5th quarter in a row with growth on the year before. Over 3 years it has grown 2.7% a year on average. The last full year, FY25, came in at $3.9 B. The last four reported quarters add to $4.1 B. FY25 revenue was $3.9 B, +3.1% on the year before. Recent pace: the last four quarters grew +9.2% on average, against 2.7% a year over the longer run, so this year is growing faster than its own long-run rate. ## How much of every $100 of sales does Solstice Advanced Materials keep? Solstice Advanced Materials, Inc.'s operating margin was 19.3% in the Jun 2026 quarter, 3.3 percentage points lower than the same quarter a year ago. Across 4 years it has been between 18.8% and 27.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −3.3 percentage points on the year while gross margin changed −2.7 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Solstice Advanced Materials' profit turning into cash? Over the last 3 years, 142% of Solstice Advanced Materials, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $455 M of operating cash against $237 M of profit. After $336 M of spending on assets, $119 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Solstice Advanced Materials' cash go? Solstice Advanced Materials, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $931 M on assets over the last 3 years. Averaged over those years that is 8.0% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $931 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Solstice Advanced Materials' P/E ratio, and how does it compare with its own history? Solstice Advanced Materials, Inc.'s P/E is 47.0×, in the middle of its own history: higher than 58% of past readings. Its usual P/E (the middle reading) is 46.4×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −60.2% while the price moved +37.0%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Solstice Advanced Materials business getting better or worse? Solstice Advanced Materials, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 7 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Solstice Advanced Materials earn on its capital? Solstice Advanced Materials, Inc. earned a ROE of 17% in FY25. We cannot compare its return on capital used with its cost of capital from the data we have. It comes from a 6.1% net margin and 0.68× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 6.1% net margin × 0.68× asset turnover × 4.12× leverage (assets divided by equity) ≈ 17.1% on equity. The margin does its share; borrowing is a big part of it. ## Does Solstice Advanced Materials have too much debt? Solstice Advanced Materials, Inc. has total debt of $2.4 B against shareholder equity of $1.6 B as of Jun 2026, so its debt is 1.53× its equity. Year by year, that ratio went from 0.08 in FY23 to 1.82 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Solstice Advanced Materials shareholding pattern? 3.1% of Solstice Advanced Materials, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.4 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Solstice Advanced Materials from balance-sheet trouble? For Solstice Advanced Materials, Inc., the Z-score is 2.77. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.77 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Solstice Advanced Materials rank in its industry? 39.4 out of 100, rank 25 of 29 in Specialty Chemicals, with 65% of the evidence available. Solstice Advanced Materials, Inc. scores 39.4 out of 100 against the 29 companies it is compared with in Specialty Chemicals, ranking 25. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 9.4 + 16.5 + 8.8 + 4.7 = 39.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Solstice Advanced Materials compared with? Solstice Advanced Materials ranks 25 of 29 Specialty Chemicals companies on the 4-Factor Sector Score, with 39.4 out of 100. 1. [Ingevity Corporation](https://www.sectoralpha.in/us/stocks/ngvt) NGVT · quiet · Most evidence points up · 66% evidence 65.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue n/a · Profit n/a · Operating margin change 6.6 points · 39% evidence Capital efficiency 18.8/25 · ROCE 23.7% · Operating margin 29.9% · 76% evidence Valuation 13.1/20 · P/E 48.1× · PEG 0.44 · 65% evidence Relative strength 11.2/20 · Lead over its industry 1.2% · Lead over S&P 500 2.1% · 1 year 52.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.1 + 18.8 + 13.1 + 11.2 = 65.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Sociedad Química y Minera de Chile S.A.](https://www.sectoralpha.in/us/stocks/sqm) SQM · quiet · Evidence leans up · 81% evidence 64.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 31.2/35 · Revenue 59% · Profit 100% · Operating margin change 32.2 points · 83% evidence Capital efficiency 18.5/25 · ROCE 18.9% · Operating margin 48.8% · 76% evidence Valuation 14.2/20 · P/E 15.2× · PEG 0.81 · 65% evidence Relative strength 0.5/20 · Lead over its industry -30.8% · Lead over S&P 500 -30.1% · 1 year 10% · 100% evidence · 0 of 12 weeks ahead Exact sum: 31.2 + 18.5 + 14.2 + 0.5 = 64.4 · What this means: Earnings are strong; relative strength in its sector is -30.8% and the one-year return is 10%. 3. [Avient Corporation](https://www.sectoralpha.in/us/stocks/avnt) AVNT · quiet · Evidence leans up · 81% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.7/35 · Revenue 2.3% · Profit 41% · Operating margin change 1.5 points · 83% evidence Capital efficiency 8.7/25 · ROCE 7.6% · Operating margin 12.8% · 76% evidence Valuation 14.3/20 · P/E 19.9× · PEG 0.46 · 65% evidence Relative strength 15.5/20 · Lead over its industry 9.4% · Lead over S&P 500 10.6% · 1 year 45.6% · 100% evidence · 8 of 12 weeks ahead Exact sum: 21.7 + 8.7 + 14.3 + 15.5 = 60.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [PPG Industries, Inc.](https://www.sectoralpha.in/us/stocks/ppg) PPG · turning · Evidence leans up · 81% evidence 60.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.3/35 · Revenue 5% · Profit 52.2% · Operating margin change -1.2 points · 83% evidence Capital efficiency 12.4/25 · ROCE 12.6% · Operating margin 14% · 76% evidence Valuation 15.3/20 · P/E 17.2× · PEG 0.29 · 65% evidence Relative strength 15.2/20 · Lead over its industry 2.8% · Lead over S&P 500 4% · 1 year 26% · 100% evidence · 1 of 12 weeks ahead Exact sum: 17.3 + 12.4 + 15.3 + 15.2 = 60.2 · What this means: Relative strength against the index is 4%, and revenue and profit growth are weak. 5. [Balchem Corporation](https://www.sectoralpha.in/us/stocks/bcpc) BCPC · breaking out · Evidence leans up · 85% evidence 59.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 9.5% · Profit 14.8% · Operating margin change 1.1 points · 95% evidence Capital efficiency 16.9/25 · ROCE 14.9% · Operating margin 21.5% · 76% evidence Valuation 8.5/20 · P/E 30.8× · PEG 1.9 · 65% evidence Relative strength 11.2/20 · Lead over its industry -1.3% · Lead over S&P 500 0% · 1 year 15% · 100% evidence · 3 of 12 weeks ahead Exact sum: 23.2 + 16.9 + 8.5 + 11.2 = 59.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 6. [Air Products and Chemicals, Inc.](https://www.sectoralpha.in/us/stocks/apd) APD · turning · Too little evidence to rank firmly · 58% evidence 59.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.9/35 · Revenue n/a · Profit n/a · Operating margin change 1.2 points · 45% evidence Capital efficiency 11.7/25 · ROCE 8.7% · Operating margin 25.5% · 76% evidence Valuation 10.0/20 · P/E 30.7× · PEG n/a · 15% evidence Relative strength 16.9/20 · Lead over its industry 3.7% · Lead over S&P 500 4.9% · 1 year 20.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 20.9 + 11.7 + 10 + 16.9 = 59.5 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 7. [Ecolab Inc.](https://www.sectoralpha.in/us/stocks/ecl) ECL · turning · Evidence leans up · 81% evidence 56.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.8/35 · Revenue 7.1% · Profit -1% · Operating margin change -0.1 points · 83% evidence Capital efficiency 15.0/25 · ROCE 13% · Operating margin 18.5% · 76% evidence Valuation 9.9/20 · P/E 37× · PEG 1.4 · 65% evidence Relative strength 17.8/20 · Lead over its industry 4.1% · Lead over S&P 500 5.6% · 1 year 19% · 100% evidence · 4 of 12 weeks ahead Exact sum: 13.8 + 15 + 9.9 + 17.8 = 56.5 · What this means: Relative strength against the index is 5.6%, and revenue and profit growth are weak. 8. [Axalta Coating Systems Ltd.](https://www.sectoralpha.in/us/stocks/axta) AXTA · quiet · Evidence leans up · 81% evidence 55.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.6/35 · Revenue -0.9% · Profit -21.8% · Operating margin change -0.5 points · 83% evidence Capital efficiency 14.9/25 · ROCE 13.4% · Operating margin 15.2% · 76% evidence Valuation 14.6/20 · P/E 21× · PEG 0.33 · 65% evidence Relative strength 12.7/20 · Lead over its industry 2.9% · Lead over S&P 500 4.4% · 1 year 21.4% · 100% evidence · 3 of 12 weeks ahead Exact sum: 13.6 + 14.9 + 14.6 + 12.7 = 55.8 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 9. [Calumet, Inc.](https://www.sectoralpha.in/us/stocks/clmt) CLMT · leader · Evidence leans up · 64% evidence 54.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.4/35 · Revenue 12.8% · Profit n/a · Operating margin change 4.8 points · 62% evidence Capital efficiency 3.4/25 · ROCE -3.7% · Operating margin -4.6% · 76% evidence Valuation 11.4/20 · P/E -42.6× · PEG n/a · 15% evidence Relative strength 16.6/20 · Lead over its industry 28.9% · Lead over S&P 500 30% · 1 year 146.6% · 100% evidence · 12 of 12 weeks ahead Exact sum: 23.4 + 3.4 + 11.4 + 16.6 = 54.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [LyondellBasell Industries N.V.](https://www.sectoralpha.in/us/stocks/lyb) LYB · breaking out · Evidence leans up · 71% evidence 54.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.2/35 · Revenue -1.8% · Profit -238.4% · Operating margin change 13.8 points · 83% evidence Capital efficiency 10.4/25 · ROCE 8.4% · Operating margin 17.9% · 76% evidence Valuation 11.5/20 · P/E -47.3× · PEG n/a · 15% evidence Relative strength 16.5/20 · Lead over its industry 3.4% · Lead over S&P 500 4.1% · 1 year 53.6% · 100% evidence · 5 of 12 weeks ahead Exact sum: 16.2 + 10.4 + 11.5 + 16.5 = 54.6 · What this means: Relative strength against the index is 4.1%, and revenue and profit growth are weak. 11. [WD-40 Company](https://www.sectoralpha.in/us/stocks/wdfc) WDFC · quiet · Evidence leans up · 85% evidence 53.8 out of 100 Growth Capital Valuation Relative
12. [The Sherwin-Williams Company](https://www.sectoralpha.in/us/stocks/shw) SHW · basing · Evidence leans up · 81% evidence 52.7 out of 100 Growth Capital Valuation Relative
13. [RPM International Inc.](https://www.sectoralpha.in/us/stocks/rpm) RPM · basing · Evidence leans up · 85% evidence 52.0 out of 100 Growth Capital Valuation Relative
14. [Hawkins, Inc.](https://www.sectoralpha.in/us/stocks/hwkn) HWKN · turning · Evidence leans up · 81% evidence 51.4 out of 100 Growth Capital Valuation Relative
15. [Sensient Technologies Corporation](https://www.sectoralpha.in/us/stocks/sxt) SXT · losing its lead · Evidence leans up · 81% evidence 50.1 out of 100 Growth Capital Valuation Relative
16. [DuPont de Nemours, Inc.](https://www.sectoralpha.in/us/stocks/dd) DD · turning · Evidence leans down · 64% evidence 49.9 out of 100 Growth Capital Valuation Relative
17. [Linde plc](https://www.sectoralpha.in/us/stocks/lin) LIN · turning · Evidence leans down · 85% evidence 48.8 out of 100 Growth Capital Valuation Relative
18. [H.B. Fuller Company](https://www.sectoralpha.in/us/stocks/ful) FUL · quiet · Evidence leans down · 85% evidence 48.2 out of 100 Growth Capital Valuation Relative
19. [Ashland Inc.](https://www.sectoralpha.in/us/stocks/ash) ASH · quiet · Evidence leans down · 64% evidence 47.4 out of 100 Growth Capital Valuation Relative
20. [International Flavors & Fragrances Inc.](https://www.sectoralpha.in/us/stocks/iff) IFF · breaking out · Evidence leans down · 64% evidence 46.9 out of 100 Growth Capital Valuation Relative
21. [Albemarle Corporation](https://www.sectoralpha.in/us/stocks/alb) ALB · quiet · Evidence leans down · 64% evidence 43.4 out of 100 Growth Capital Valuation Relative
22. [Cabot Corporation](https://www.sectoralpha.in/us/stocks/cbt) CBT · quiet · Evidence leans down · 81% evidence 42.1 out of 100 Growth Capital Valuation Relative
23. [Element Solutions Inc](https://www.sectoralpha.in/us/stocks/esi) ESI · quiet · Evidence leans down · 85% evidence 40.9 out of 100 Growth Capital Valuation Relative
24. [NewMarket Corporation](https://www.sectoralpha.in/us/stocks/neu) NEU · quiet · Evidence leans down · 81% evidence 40.9 out of 100 Growth Capital Valuation Relative
25. Solstice Advanced Materials, Inc. this page SOLS · turning · Evidence leans down · 65% evidence 39.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 9.4/35 · Revenue 9.2% · Profit -59.3% · Operating margin change -3.3 points · 83% evidence Capital efficiency 16.5/25 · ROCE 16.6% · Operating margin 19.3% · 76% evidence Valuation 8.8/20 · P/E 67× · PEG n/a · 15% evidence Relative strength 4.7/20 · Lead over its industry -11.5% · Lead over S&P 500 -11% · 1 year 30% · 70% evidence · 0 of 12 weeks ahead Exact sum: 9.4 + 16.5 + 8.8 + 4.7 = 39.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 26. [Eastman Chemical Company](https://www.sectoralpha.in/us/stocks/emn) EMN · basing · Evidence leans down · 81% evidence 38.0 out of 100 Growth Capital Valuation Relative
27. [Quaker Chemical Corporation](https://www.sectoralpha.in/us/stocks/kwr) KWR · quiet · Evidence leans down · 64% evidence 37.4 out of 100 Growth Capital Valuation Relative
28. [Westlake Corporation](https://www.sectoralpha.in/us/stocks/wlk) WLK · basing · Most evidence points down · 64% evidence 34.8 out of 100 Growth Capital Valuation Relative
29. [Perimeter Solutions, Inc.](https://www.sectoralpha.in/us/stocks/prm) PRM · quiet · Most evidence points down · 64% evidence 29.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Specialty Chemicals](https://www.sectoralpha.in/us/sectors/specialty-chemicals), all 29 compared on one page. ## Which companies are close to Solstice Advanced Materials in size? Solstice Advanced Materials is the 13th largest of 47 Specialty Chemicals companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: RPM International Inc., Albemarle Corporation and Sasol. Just below it: Westlake Corporation, Element Solutions Inc and Axalta Coating Systems. ### Specialty Chemicals companies close in size

1. [RPM International Inc.](https://www.sectoralpha.in/us/stocks/rpm) $13.4 billion
2. [Albemarle Corporation](https://www.sectoralpha.in/us/stocks/alb) $10.6 billion
3. [Sasol Limited](https://www.sectoralpha.in/us/stocks/ssl) $10.1 billion
4. Solstice Advanced Materials, Inc. $9.8 billion
5. [Westlake Corporation](https://www.sectoralpha.in/us/stocks/wlk) $8.8 billion
6. [Element Solutions Inc](https://www.sectoralpha.in/us/stocks/esi) $8.5 billion
7. [Axalta Coating Systems Ltd.](https://www.sectoralpha.in/us/stocks/axta) $7.5 billion

[All 47 Specialty Chemicals companies, largest first](https://www.sectoralpha.in/us/sectors/specialty-chemicals#all-companies)

### Companies close in size in other industries

1. [Sunoco LP](https://www.sectoralpha.in/us/stocks/sun) $9.4 billion · Oil & Gas Refining & Marketing
2. [Onto Innovation Inc.](https://www.sectoralpha.in/us/stocks/onto) $9.4 billion · Semiconductor Equipment & Materials
3. Solstice Advanced Materials, Inc. $9.4 billion
4. [Allison Transmission Holdings, Inc.](https://www.sectoralpha.in/us/stocks/alsn) $9.3 billion · Auto Parts
5. [Jackson Financial Inc.](https://www.sectoralpha.in/us/stocks/jxn) $9.3 billion · Insurance - Life

## What else do people ask about Solstice Advanced Materials? ### What were Solstice Advanced Materials's latest quarterly results? Solstice Advanced Materials, Inc. reported revenue of $1.1 B and net profit of $119 M for the Jun 2026 quarter. Revenue rose 11.1% and profit rose 22.7% compared with a year earlier. Earnings per share were $0.75. The operating margin was 19.3%, 3.3 percentage points lower than a year earlier (as of 3 November 2026). ### What is Solstice Advanced Materials's market cap? Solstice Advanced Materials, Inc.'s market capitalisation is $9.8 B at a stock price of $61.74. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Solstice Advanced Materials performing? Solstice Advanced Materials, Inc.'s latest readings are below. In its latest quarter, revenue rose 11.1% and profit rose 22.7% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 1 week running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Solstice Advanced Materials's stock price go up? This page does not forecast Solstice Advanced Materials, Inc.'s stock price. What it shows instead: the stock price is $61.74. Its P/E of 47.0× is higher than 58% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Solstice Advanced Materials in its business cycle? Solstice Advanced Materials, Inc.'s FY25 operating margin was 18.8%, against a 4-year range of 18.8% to 27.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 19.3%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Solstice Advanced Materials story? The main question: the share price moved +37.0% in a year while yearly earnings per share moved −60.2%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Solstice Advanced Materials a stock worth studying right now? What the numbers show: Solstice Advanced Materials, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.